Sign In
Buy DHR
$178.08
+1.97 (+1.12%)
At Close: Jun 03, 2026
BLCO vs. DHR: Which Stock Should Value Investors Buy Now?
12:41pm, Thursday, 02'nd Oct 2025
Investors looking for stocks in the Medical Services sector might want to consider either Bausch + Lomb (BLCO) or Danaher (DHR). But which of these two stocks offers value investors a better bang for
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
05:10pm, Wednesday, 01'st Oct 2025
NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher
Danaher: Balanced Portfolio With Upside Potential In 2026
06:33am, Wednesday, 01'st Oct 2025
Danaher is undervalued, with strong fundamentals, robust free cash flow, and a "Buy" rating targeting $210 (12.7% upside). DHR's bioprocessing segment drives growth, balancing Life Sciences weakness,
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
01:30pm, Sunday, 28'th Sep 2025
NEW YORK, Sept. 28, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher
NEW YORK , Sept. 26, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Co
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR
09:11pm, Tuesday, 23'rd Sep 2025
NEW YORK , Sept. 23, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Co
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
04:44pm, Tuesday, 23'rd Sep 2025
NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher
Danaher Schedules Third Quarter 2025 Earnings Conference Call
04:15pm, Tuesday, 23'rd Sep 2025
WASHINGTON , Sept. 23, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2025 on Tuesday, October 21, 20
Can Danaher's Diagnostics Unit Sustain Growth Amid Lower Sales in China?
10:36am, Monday, 22'nd Sep 2025
DHR's Diagnostics unit posts steady Q2 growth, led by Beckman Coulter demand, while China headwinds weigh on results.
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
12:34pm, Saturday, 20'th Sep 2025
NEW YORK, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
12:42pm, Wednesday, 17'th Sep 2025
NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher
Danaher's Life Sciences Segment Shrinks: What's the Path Forward?
12:06pm, Tuesday, 16'th Sep 2025
DHR's Life Sciences unit faces revenue declines from weak demand, but new products and biotech advances offer growth potential.
NEW YORK , Sept. 15, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
04:57pm, Thursday, 11'th Sep 2025
NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher
Danaher's Biotechnology Growth Picks Up: A Sign of More Upside?
12:56pm, Thursday, 11'th Sep 2025
DHR's Biotechnology unit grows 6% in Q2, driven by bioprocessing, despite weakness in research equipment demand.
